I specialize in the care of children with lymphomas, especially cancers that have returned despite prior treatment. I also conduct clinical research to design and assess investigational therapies — particularly antibodies and new targeted agents that take aim at the molecular signaling pathways that drive cancer growth — for children with all types of cancer.
I am a co-founder of POETIC (Pediatric Oncology Experimental Therapeutics Investigator Consortium), a collaboration between multiple centers around the country whose mission is the development of biologically targeted therapies for cancers that have recurred in children. We started POETIC in February 2003 to increase patients’ access to promising new agents in clinical trials. I serve as Director of the POETIC Coordinating Center at Memorial Sloan-Kettering, the only POETIC center in New York City.